RE Dickinson Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$101K Sell
387
-1,765
-82% -$524K 0.06% 66
2024
Q3
$693K Hold
2,152
0.39% 25
2024
Q2
$672K Hold
2,152
0.41% 25
2024
Q1
$612K Hold
2,152
0.38% 26
2023
Q4
$620K Hold
2,152
0.41% 24
2023
Q3
$578K Hold
2,152
0.41% 26
2023
Q2
$478K Hold
2,152
0.18% 61
2023
Q1
$520K Hold
2,152
0.18% 64
2022
Q4
$565K Sell
2,152
-10
-0.5% -$2.68K 0.23% 54
2022
Q3
$487K Hold
2,162
0.4% 27
2022
Q2
$526K Hold
2,162
0.07% 29
2022
Q1
$523K Hold
2,162
0.35% 26
2021
Q4
$486K Buy
+2,162
New +$456K 0.37% 25

Other funds holding AMGN

RE Dickinson Investment Advisors's AMGN Position: Q4 2024 in Review

RE Dickinson Investment Advisors reduced its Amgen (AMGN) stake by 82% in Q4 2024, selling an estimated $524K and leaving 387 shares worth $101K. The position accounts for 0.06% of the portfolio, ranked #66.

RE Dickinson Investment Advisors first reported a position in AMGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $693K in Q3 2024. 2,860 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • RE Dickinson Investment Advisors held 387 shares of Amgen worth $101K as of Q4 2024.
  • RE Dickinson Investment Advisors sold 1,765 Amgen shares in Q4 2024, an estimated $524K.
  • Amgen made up 0.06% of RE Dickinson Investment Advisors's portfolio in Q4 2024, its #66 holding.
  • RE Dickinson Investment Advisors first reported a position in Amgen in Q4 2021 and has held it in 13 quarters since.
  • RE Dickinson Investment Advisors's Amgen position peaked at $693K in Q3 2024.
  • 2,860 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.